A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
Clinical trial NCT00096954 · COMPLETED
Trial details
- NCT number
- NCT00096954
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2010-09-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.